Figure 1. Estimated Probability Of Achieving Initial Headache Response Within 4 Hours Of Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig1)
Sumatriptan Tablet
Product Images NDC 63187-797
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sumatriptan (NDC 63187-797). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 2. The Estimated Probability Of Patients Taking A Second Dose Of Sumatriptan Tablets Or Other Medication To Treat Migraine Over The 24 Hours Following The Initial Dose Of Study Treatment In Pooled Trials 1, 2, And 3a (Sumatriptan Fig2)
63187-797-09 (Sumatriptan Fig4)
This is a drug information label featuring Sumatriptan 50mg tablets manufactured by Aurobindo Pharma Limited in Hyderabad, India. The tablets are packaged in a bottle of nine tablets, and the product ID is RS079709. The lot number and expiration date are provided, along with the National Drug Code of the product. Instructions are given to keep the medication out of the reach of children, store it in a cool environment, and that it is for prescription-only.*
Chemical Structure (Sumatriptan Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
